Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial.
Veronica F QuinnBettina MeiserKatherine TuckerKathy M TuckerKaaren J WattsBelinda RahmanMichelle PeateChristobel M SaundersElizabeth GeelhoedMargaret GleesonKristine Barlow-StewartMichael FieldMarion HarrisYoland C AntillLinda CicciarelliKaren CroweMichael T BowenGillian MitchellPublished in: Genetics in medicine : official journal of the American College of Medical Genetics (2016)
A streamlined model of educating women newly diagnosed with breast cancer about TFGT seems to be a cost-effective way of delivering education while ensuring that women feel informed and supported in their decision making, thus freeing resources for other women to access TFGT.Genet Med 19 4, 448-456.
Keyphrases
- newly diagnosed
- polycystic ovary syndrome
- decision making
- breast cancer risk
- pregnancy outcomes
- healthcare
- cervical cancer screening
- clinical trial
- study protocol
- type diabetes
- metabolic syndrome
- insulin resistance
- randomized controlled trial
- dna methylation
- adipose tissue
- pregnant women
- copy number
- combination therapy